Bitcoin

As growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs


Novo Nordisk’s Karsten Munk Knudsen is targeting 800 million obese people globally. Read More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button